Immucell (ICCC) Gross Profit (2010 - 2026)
Immucell's (ICCC) quarterly Gross Profit came in at $2.9 million in Q4 2025, up 2.77% YoY from $2.8 million in Q4 2024, and up 23.15% on a QoQ basis from $2.4 million in Q3 2025.
Immucell (ICCC) Gross Profit (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Gross Profit data on file, last reported at $2.9 million in Q4 2025.
- Quarterly Gross Profit rose 2.77% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.4 million (up 44.13% YoY) and the FY2025 annual result came in at $11.4 million, up 44.13% from the prior year.
- Gross Profit improved to $2.9 million in Q4 2025, from $2.4 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $3.4 million in Q1 2025 to a low of $300775.0 in Q1 2023.
- A 5-year average of $2.0 million and a median of $2.1 million in 2021 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit tumbled 90.31% — and 2024, when it jumped 663.15%.
- Tracing ICCC's Gross Profit over 5 years: stood at $2.6 million in 2021, then tumbled by 61.25% to $992176.0 in 2022, then rose by 27.69% to $1.3 million in 2023, then jumped by 123.51% to $2.8 million in 2024, then grew by 2.77% to $2.9 million in 2025.
- The last three Gross Profit figures came in at $2.9 million (Q4 2025), $2.4 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.44 Mn |
| Jun 30, 2026 | 2.44 Mn |
| Dec 31, 2025 | 2.91 Mn |
| Dec 31, 2025 | 2.91 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.27 Mn |